Memo Therapeutics’ CHF 37 Million Series B Financing Round

Walder Wyss advised Adjuvant Capital.Memo Therapeutics AG, an innovator in the field of antibody discovery and development, announced the close of an oversubscribed Series B financing…

This content is for members only.
Login to Read More Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for members only.
Login to Read More Join Now